Liberia  to receive experimental Ebola drug to treat victims

Liberia will receive the untested experimental drug, Zmapp, to treat people infected with Ebola. 

The move comes after a request to the US by Liberian President Ellen Johnson Sirleaf. 

The news came as medical ethics specialists met in Geneva to explore the use of such new treatments. 

BBC